Cumberland Pharmaceutical News - CPIX

Company Name	Stock Ticker Symbol	Market	Type
Cumberland Pharmaceutical Inc	CPIX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.03	1.86%	1.64	10:07:07

Open Price	Low Price	High Price	Close Price	Prev Close
1.64	1.64	1.64		1.61

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/02/2024	16:05	PRNUS	NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE..
3/05/2024	17:10	EDGAR2	Form 8-K - Current report
3/05/2024	16:05	PRNUS	Cumberland Pharmaceuticals Reports Annual 2023 Financial..
2/27/2024	16:05	PRNUS	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL..
2/09/2024	17:27	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/28/2023	17:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/28/2023	17:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/28/2023	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/27/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/15/2023	16:14	EDGAR2	Form DEL AM - Delaying amendment
12/14/2023	17:09	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/06/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/06/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/06/2023	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/17/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/07/2023	17:21	EDGAR2	Form 8-K - Current report
11/07/2023	16:05	PRNUS	Cumberland Pharmaceuticals Reports Third Quarter 2023..
11/03/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/31/2023	16:05	PRNUS	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023..
10/17/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/13/2023	09:11	EDGAR2	Form 8-K - Current report
10/10/2023	16:05	PRNUS	NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN..
10/03/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/03/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/27/2023	10:55	DJN	Correction to SEC Fines Article
9/27/2023	10:43	DJN	SEC Fines 5 Public Companies, Insiders Over Reporting..
9/19/2023	09:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/08/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/08/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/08/2023	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/11/2023	17:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	17:23	EDGAR2	Form 8-K - Current report
8/08/2023	16:05	PRNUS	Cumberland Pharmaceuticals Reports Revenue and Earnings..
8/01/2023	16:05	PRNUS	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023..
6/30/2023	17:20	EDGAR2	Form 8-K - Current report
6/26/2023	09:00	PRNUS	NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN..
5/23/2023	09:00	PRNUS	CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND..
5/15/2023	09:00	PRNUS	CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN..
5/09/2023	16:05	PRNUS	Cumberland Pharmaceuticals Reports First Quarter 2023..
5/02/2023	16:05	PRNUS	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023..